Pharmacokinetic-pharmacodynamic integration of moxifloxacin in rabbits after intravenous, intramuscular and oral administration

Journal of Veterinary Pharmacology and Therapeutics

Volumn 28, Issue 4, 2005, Pages 343-348

  Fernández Varón, Emilio ^a   Bovaira, M J ^a   Espuny, A ^a   Escudero, E ^a   Vancraeynest, D ^b   Carceles C M ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MOXIFLOXACIN;

ANIMAL EXPERIMENT; ANTIBACTERIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; COMPARTMENT MODEL; CONTROLLED STUDY; DISTRIBUTION VOLUME; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; STAPHYLOCOCCUS AUREUS;

ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; CROSS-OVER STUDIES; FEMALE; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAMUSCULAR; MALE; MICROBIAL SENSITIVITY TESTS; QUINOLINES; RABBITS; STAPHYLOCOCCUS AUREUS;

ORYCTOLAGUS CUNICULUS;

EID: 23244433595     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2005.00665.x     Document Type: Article

References (33)

1. Abd El-Aty, A.M., Goudah, A., Ismail, M., Mounir, S.M. & Shimoda, M. (2005) Disposition kinetics of difloxacin in rabbit after intravenous and intramuscular injection of dicural. Veterinary Research Communications, 29, 297-304.
2. Aliabadi, F.S. & Lees, P. (2001) Pharmacokinetics and pharmacodynamics of danofloxacin in serum and tissue fluids of goats following intravenous and intramuscular administration. American Journal of Veterinary Research, 62, 1979-1989.
3. Andes, D. & Craig, W.A. (2002) Animal model pharmacokinetics and pharmacokynamics: a critical review. International Journal of Antimicrobial Agents, 19, 261-268.
4. Ball, B. (2000) Moxifloxacin (Avelox): an 8-methoxyquinolone antibacterial with enhanced potency. International Journal of Clinical Practice, 54, 329-332.
5. Blondeau, J.M. & Hansen, G.T. (2001) Moxifloxacin: a review of the microbiological, pharmacological, clinical and safety features. Expert Opinion on Pharmacotherapy, 2, 317-335.
6. Bousquet-Melou, A., Bernard, S., Schneider, M. & Toutain, P.L. (2002) Pharmacokinetics of marbofloxacin in horses. Equine Veterinary Journal, 34, 366-372.
7. Broome, R.L., Brooks, D.L., Babish, J.G., Copeland, D.D. & Conzelman, G.M. (1991) Pharmacokinetic properties of enrofloxacin in rabbits. American Journal of Veterinary Research, 52, 1835-1841.
8. Brown, S.A. (1996) Fluorquinolones in animal health. Journal of Veterinary Pharmacology and Therapeutics, 19, 1-14.
9. Cester, C., Schneider, M. & Toutain, P.L. (1996) Comparative kinetics of two orally administered fluoroquinolones in dog: enrofloxacin versus marbofloxacin. Revue de Medecine Veterinaire, 147, 703-716.
10. Devriese, L.A., Hendrickx, W., Godard, C., Okerman, L. & Haesebrouck, F. (1996) A new pathogenic Staphylococcus aureus type in commercial rabbits. Journal of Veterinary Medicine B, 43, 313-315.
11. Drusano, G.L., Johnson, D.E., Rosen, M. & Standiford, H. (1993) Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis. Antimicrobial Agents and Chemotherapy, 37, 483-490.
12. Gardner, S.Y., Davis, J.L., Jones, S.L., Lafevers, D.H., Hoskins, M.S., Mcarver, E.M. & Papich, M.G. (2004) Moxifloxacin pharmacokinetics in horses and disposition into phagocytes after oral dosing. Journal of Veterinary Pharmacology and Therapeutics, 27, 57-60.
13. Gaur, A., Saini, S.P.S., Garg, S.K., Chaudhary, R.K. & Srivastava, A.K. (2004) Pharmacokinetics of ofloxacin after a single intravenous bolus dose in neonatal calves. Journal of Veterinary Pharmacology and Therapeutics, 25, 115-117.
14. Gibaldi, M. & Perrier, P. (1982) Pharmacokinetics 2nd edn. Marcel Dekker, New York.
15. Hermans, K., De Herdt, P., Devriese, L.A., Hendrickx, W., Godard, C. & Haesebrouck, F. (1999) Colonisation of rabbits with Staphylococcus aureus in flocks with and without chronic staphylococcosis. Veterinary Microbiology, 67, 37-46.
16. Langston, V.C., Sedrish, S. & Boothe, D.M. (1996) Disposition of single-dose oral enrofloxacin in the horse. Journal of Veterinary Pharmacology and Therapeutics, 19, 316-319.
17. Lees, P. & Aliabadi, F.S. (2002) Marbofloxacin in equine medicine: have we got the doses right? Equine Veterinary Journal, 34, 322-325.
18. Lode, H., Borner, K. & Koeppe, P. (1998) Pharmacodynamics of fluoroquinolones. Clinical Infectious Disease, 27, 33-39.
19. Marangos, M.N., Zhu, Z., Nicolau, D.P., Klepser, M.E. & Nightingale, C.H. (1997) Disposition of ofloxacin in female new Zealand white rabbits. Journal of Veterinary Pharmacology and Therapeutics, 20, 17-20.
20. NCCLS (2002) Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standard. NCCLS document, M31-A2 (ISBN: 1-56238-461-9). NCCLS, 940 West Valley Road, Suite 1400, Wayne, PA, USA.
21. Powers, J. (1990) Statistical analysis of pharmacokinetic data. Journal of Veterinary Pharmacology and Therapeutics, 13, 113-120.
22. Seguin, M.A., Papich, M.G., Sigle, K.J., Gibson, N.M. & Levy, J.K. (2004) Pharmacokinetics of enrofloxacin in neonatal kittens. American Journal of Veterinary Research, 65, 350-356.
23. Shumaker, R.C. (1986) PKCALC: a basic interactive computer program for statistical and pharmacokinetic analysis of data. Drug Metabolism Reviews, 17, 331-348.
24. Siefert, H.M., Kohlsdorfer, C., Steinke, W. & Witt, A. (1999a) Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: tissue distribution in male rats. Journal of Antimicrobial Chemotherapy, 43 (Suppl. B), 61-67.
25. Siefert, H.M., Domdey-Bette, A., Henninger, F., Hucke, F., Kohlsdorfer, C., Steinke, W. & Stass, H.H. (1999b) Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: a comparison in humans and other mammalian species. Journal of Antimicrobial Chemotherapy, 43 (Suppl. B), 69-76.
26. Spreng, M., Deleforge, J., Thomas, E., Boisrame, B. & Drugeon, H. (1995) Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolates. Journal of Veterinary Pharmacology and Therapeutics, 18, 284-289.
27. Stass, H. (1999) Absorption and bioavailability of moxifloxacin. Drugs, 58, 227-228.
28. Stass, H. & Kubitza, D. (1999) Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man. Journal of Antimicrobial Chemotherapy, 43, 83-90.
29. Stass, H., Dalhoff, A., Kubitza, D. & Schühly, U. (1998) Pharmacokinetics, safety, and tolerability of ascending single of moxifloxacin, a new 8-metoxy quinolone administered to healthy subjects. Antimicrobial Agents and Chemotherapy, 42, 2060-2065.
30. Toutain, P.L., Del Castillo, J.R.E. & Bousquet-Mélou, A. (2002) The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics. Research in Veterinary Science, 73, 105-114.
31. Turnidge, J. (1999) Pharmacokinetics and pharmacodynamics of fluoroquinolones. Drugs, 58, 29-36.
32. Yamaoka, K., Nakagawa, T. & Uno, T. (1978) Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. Journal of Pharmacokinetics and Biopharmaceutics, 6, 165-175.
33. Yamaoka, K., Tamigawara, Y. & Uno, J. (1981) A pharmacokinetic analysis program (MULTI) for microcomputers. Journal of Pharmacobiodynamics, 4, 879-885.